LIPOCINE INC. Assets, Fair Value Disclosure
LIPOCINE INC. (LPCN) had Assets, Fair Value Disclosure of $23.16 million as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Notes › Fair Value, Net Asset (Liability)
us-gaap:AssetsFairValueDisclosure · last filed 2026-08-04
- 2026-06-30: Assets, Fair Value Disclosure $23.16M.
- 2026-03-31: Assets, Fair Value Disclosure $23.89M.
- 2025-12-31: Assets, Fair Value Disclosure $14.18M.
- 2025-09-30: Assets, Fair Value Disclosure $15.06M.
| Period end | Assets, Fair Value Disclosure |
|---|---|
| 2026-06-30 | $23.16M 10-Q · filed 2026-08-04 |
| 2026-03-31 | $23.89M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $14.18M 10-Q · filed 2026-08-04 |
| 2025-09-30 | $15.06M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $17.65M 10-Q · filed 2025-08-05 |
| 2025-03-31 | $19.71M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $21.58M 10-K · filed 2026-03-10 |
| 2024-09-30 | $19.82M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $22.74M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $24.50M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $21.96M 10-K · filed 2025-03-13 |
| 2023-09-30 | $23.97M 10-Q · filed 2023-11-08 |
| 2023-06-30 | $25.67M 10-Q · filed 2023-08-10 |
| 2023-03-31 | $28.45M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $32.08M 10-K · filed 2024-03-07 |
| 2022-09-30 | $33.72M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $37.17M 10-Q · filed 2022-08-08 |
| 2022-03-31 | $41.20M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $45.78M 10-K · filed 2023-03-10 |
| 2021-09-30 | $38.23M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $45.85M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $49.20M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $18.85M 10-K · filed 2022-03-09 |
| 2020-09-30 | $18.31M 10-Q · filed 2020-11-10 |
| 2020-06-30 | $17.52M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $14.76M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $13.26M 10-K · filed 2021-03-11 |
| 2019-09-30 | $11.14M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $13.86M 10-Q · filed 2019-08-07 |
| 2019-03-31 | $16.59M 10-Q · filed 2019-05-08 |
| 2018-12-31 | $14.50M 10-K · filed 2020-03-13 |
| 2018-09-30 | $16.42M 10-Q · filed 2018-11-07 |
| 2018-06-30 | $19.71M 10-Q · filed 2018-08-07 |
| 2018-03-31 | $26.99M 10-Q · filed 2018-05-07 |
| 2017-12-31 | $20.43M 10-K · filed 2019-03-06 |
| 2017-09-30 | $21.38M 10-Q · filed 2017-11-08 |
| 2017-06-30 | $21.32M 10-Q · filed 2017-08-07 |
| 2017-03-31 | $23.25M 10-Q · filed 2017-05-08 |
| 2016-12-31 | $24.20M 10-K · filed 2018-03-12 |
| 2016-09-30 | $25.09M 10-Q · filed 2016-11-08 |
| 2016-06-30 | $25.07M 10-Q · filed 2016-08-09 |
| 2016-03-31 | $24.97M 10-Q · filed 2016-05-09 |
| 2015-12-31 | $24.90M 10-K · filed 2017-03-06 |
| 2015-09-30 | $24.90M 10-Q · filed 2015-11-12 |
| 2015-06-30 | $24.89M 10-Q · filed 2015-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |